Market Tracker

08/21 5:16pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

149.01
Delayed Data
As of 4:00pm ET
 +0.88 / +0.59%
Today’s Change
71.46
Today|||52-Week Range
167.86
+102.27%
Year-to-Date

Today’s Trading

Previous close148.13
Today’s open148.00
Day’s range147.42 - 150.26
Volume1,090,074
Average volume (3 months)1,914,345
Market cap$37.3B
Dividend yield--
Data as of 4:00pm ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)+80.09%
Earnings growth (this year)+94.87%
Earnings growth (next 5 years)+68.00%
Revenue growth (last year)+64.89%
P/E ratio144.7
Price/Sales10.59
Price/Book31.80

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.24+0.39%
SHPGShire-4.70-3.23%
ALXNAlexion Pharmaceutic...+0.03+0.02%
ZTSZoetis Inc+0.60+0.99%
Data as of 4:01pm ET, 08/21/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$0.35
Annual revenue (last year)$1.7B
Annual profit (last year)-$112.1M
Net profit margin-6.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
EVP, Chief Operating &
Financial Officer
Ian F. Smith
Corporate headquarters
Boston, Massachusetts

Forecasts